www.analyticsdrift.com
Image source: Analytics Drift
OpenAI and Retro Biosciences, a longevity startup, have come together to train a micro-AI model, GPT-4b, which will improve stem cell production.
Image source: AD
Previously, Google DeepMind’s AlphaFold dominated the AI Bioengineering application, as it facilitated the structure of protein structures.
Image source: Google
According to the OpenAI researchers, GPT-4b is said to visualize proteins that transform regular adult cells into stem cells. This feature overpowers the capability of the DeepMind’s AlphaFold, as it improves stem cell production efficiency.
Image source: AD
Although in its micro stage, the model can help re-engineer the Yamanaka factor, representing four genes responsible for combatting aging issues.
Image source: Canva
Referred to as a small language model (SLM), GPT-4b is trained using data on different protein species and the interaction process of different cells.
Image source: AD
As Retro Biosciences has been working towards increasing human lifespan by 10 years, it is gaining traction from tech giants. Sam Altman, CEO of OpenAI, has already funded this protein engineering project with a total of $180 Million.
Image source: Canva